New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 7, 2013
10:01 EDTABBV, VRTX, TRLA, DLA, MLNX, PFE, VCLK, OPTR, FIO, SYRG, RBCN, FLY, GOOGOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: Delta Apparel (DLA) initiated with a Buy at Roth Capital... Fly Leasing (FLY) initiated with a Buy at Deutsche Bank... Google (GOOG) initiated with a Neutral at Sterne Agee... Optimer (OPTR) initiated with an Outperform at RW Baird... Trulia (TRLA) initiated with a Neutral at Goldman... ValueClick (VCLK) initiated with a Buy at Goldman... Vertex (VRTX) initiated with an Outperform at RW Baird... Rubicon (RBCN) coverage resumed with an Underweight at Piper Jaffray... Synergy Resources (SYRG) initiated with a Buy at Canaccord... Pfizer (PFE) reinstated with a Neutral at Credit Suisse... AbbVie (ABBV) initiated with a Neutral at Credit Suisse... Fusion-io (FIO) initiated with a Neutral at Janney Capital... Mellanox (MLNX) initiated with a Buy at Janney Capital.
News For GOOG;DLA;FLY;OPTR;TRLA;RBCN;VCLK;VRTX;SYRG;PFE;ABBV;FIO;MLNX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | all recent news | >>
March 18, 2015
05:43 EDTGOOGGoogle introduces new app approval process
Subscribe for More Information
March 17, 2015
14:13 EDTGOOGMorgan Stanley questions GM capital allocation plan
Subscribe for More Information
09:27 EDTGOOGApple plans to allow trade-ins of Android, BlackBerry devices, Bloomberg says
Subscribe for More Information
09:07 EDTGOOGDISH's Sling TV launches on Xbox One
Subscribe for More Information
09:05 EDTGOOGMicrosoft Band now available at Best Buy, Target, Amazon, Re/code reports
Subscribe for More Information
08:03 EDTABBVAbbVie to present data from 22 HUMIRA abstracts at AAD
Subscribe for More Information
07:42 EDTGOOGBoeing may produce satellite for tech giants, Reuters says
Subscribe for More Information
06:37 EDTGOOGAfter losing marketshare, Google now asks Firefox users to switch, BI says
Subscribe for More Information
06:31 EDTABBVStudies find Gilead's hepatitis C drugs cost effective, Reuters says
Subscribe for More Information
05:57 EDTGOOGChina vendors to ship 50M Androids with fingerprint sensors, DigiTimes reports
China vendors is expected to ship 50M Android (GOOG) smartphones with fingerprint sensors in 2015, reports DigiTimes. According to sources at Taiwan-based IC backend service companies, Android smartphone vendors have adopted sliding-type fingerprint sensors, which are more competitive in pricing compared to press-type sensors used by Apple (AAPL). Reference Link
March 16, 2015
15:04 EDTABBVPharmacyclics says committee recommends unblinding after primary endpoint met
Subscribe for More Information
14:13 EDTGOOGApple to offer Android users rebates to switch to iPhones, 9to5Mac says
Subscribe for More Information
11:35 EDTSYRGSynergy Resources management to meet with Johnson Rice
Meeting to be held in Chicago on March 18 hosted by Johnson Rice.
06:40 EDTPFEPCSK9 studies show potential improvement in heart health, WSJ says
Subscribe for More Information
March 13, 2015
11:36 EDTGOOGGoogle Apps security breach affects 282,867 domain owners, The Next Web says
Personal information for 282,867 Google Apps domain owners was exposed Friday, reports The Next Web, citing Google statements and a Cisco report. Names, addresses, email information, and phone numbers were made public, though a Google spokesperson stated, "We identified the root cause, made the appropriate fixes, and communicated this with affects Apps customers." Presently there is no evidence of malicious use. Reference Link
11:19 EDTVRTXBioMarin rallies amid positive call on DMD drug timeline, takeover rumor
The shares of drug maker BioMarin (BMRN) are climbing after research firm Jefferies quoted a regulatory expert as saying that the company's drisapersen drug has a good chance of being approved on an accelerated basis by the FDA. Drisapersen is a treatment for Duchenne Muscular Dystrophy, or DMD. WHAT'S NEW: "There is a strong possibility" that the FDA will grant accelerated approval to drisapersen because there is currently no approved drug for the treatment of DMD, Jefferies analyst Eun Yang quoted the expert as saying. The expert is also optimistic about the outlook for accelerated approval because she had a good experience working with BioMarin while she was with the FDA and because BioMarin has a favorable track record with the FDA, according to Yang. There is a 60% chance that drisapersen will be approved by the end of this year and the stock can rise to $155, versus its current level of about $121.50, if that does occur, the analyst stated. Yang's price target on the stock increased to $135 from $125 and the analyst kept a Buy rating on the shares. WHAT'S NOTABLE: Pharmaceutical giant AstraZeneca (AZN) has been rumored to be interested in buying BioMarin for $175 per share in cash, British newspaper Daily Mail reported. , Piper Jaffray analyst Joshua Schimmer wrote in a note to investors this morning that BioMarin, along with Vertex (VRTX) and Incyte (INCY), have a "clear path" to joining the group of companies with market caps of over $10B projected to deliver greater than 20% EPS CAGR, which the analyst identified as a set of criteria that has previously pointed to companies that make good potential takeover targets. PRICE ACTION: In mid-morning trading, BioMarin climbed nearly 4% to $120.
09:50 EDTGOOGActive equity options trading on open
Subscribe for More Information
08:21 EDTGOOGGoogle price target raised to $681 from $640 at Cowen
Subscribe for More Information
08:20 EDTGOOGGoogle not making aggressive domain name push, NY Post says
Subscribe for More Information
05:54 EDTGOOGIDC: Worldwide tablet long term growth in low single digits, Digitimes says
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use